- Grandis, Jennifer;
- Nakajima, EC;
- Laymon, C;
- Oborski, M;
- Hou, W;
- Wang, L;
- Grandis, JR;
- Ferris, RL;
- Mountz, JM;
- Van, B
Purpose: Intratumoral metabolic heterogeneity may increase the likelihood of treatment failure due to the presence of a subset of resistant tumor cells. Using a head and neck squamous cell carcinoma (HNSCC) xenograft model and a real-time fluorescence imag